BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs7903146
,
DRD2
,
Coagulation
,
Arthritis
,
Intestine
,
Early pregnancy factor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CB(1
Summary
General Info
Curated Studies
Most Correlated Studies
Striata of B6.D2 congenic mice with QTL influencing methamphetamine - induced locomotor activity
Explore Curated Studies Results
Literature
Most Relevant Literature
Myxococcus xanthus PilB interacts with c-di-GMP and modulates motility and biofilm formation.
Implication of Staphylococcus aureus MsrB dimerization upon oxidation.
High-Throughput Screen for Inhibitors of the Type IV Pilus Assembly ATPase PilB.
Generation of High Current Densities in Geobacter sulfurreducens Lacking the Putative Gene for the P…
PilB from Streptococcus sanguinis is a bimodular type IV pilin with a direct role in adhesion.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety & Efficacy Study of rAAV1-CB-hAAT for Alpha-1 Antitrypsin Deficiency
An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participant…
A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors
A Phase 1/2 Study CB-103 With or Without Venetoclax in Patients With NOTCH ACC
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulga…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ